These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17415055)

  • 1. Polymorphisms in the 3' untranslated region of the fractalkine (CX3CL1) gene and the risk of HIV-1 infection and disease progression.
    Peraire J; Vidal F; Plana M; Domingo P; Coll B; Viladés C; Garcia F; Veloso S; Gatell JM; Broch M
    AIDS; 2007 Apr; 21(7):891-3. PubMed ID: 17415055
    [No Abstract]   [Full Text] [Related]  

  • 2. The CX3CL1-CX3CR1 system and psoriasis.
    Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
    Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and targeting of CX3CL1 (fractalkine) in renal tubular epithelial cells.
    Durkan AM; Alexander RT; Liu GY; Rui M; Femia G; Robinson LA
    J Am Soc Nephrol; 2007 Jan; 18(1):74-83. PubMed ID: 17151328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adhesional chemokine, fractalkine].
    Umehara H
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Apr; 23(2):90-102. PubMed ID: 10863324
    [No Abstract]   [Full Text] [Related]  

  • 5. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea.
    Gangemi S; Cannavò SP; Guarneri F; Merendino RA; Sturniolo GC; Minciullo PL; Di Pasquale G; Valenzise M; Drago F; Rebora A
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1366-7. PubMed ID: 17062081
    [No Abstract]   [Full Text] [Related]  

  • 6. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients.
    Foussat A; Bouchet-Delbos L; Berrebi D; Durand-Gasselin I; Coulomb-L'Hermine A; Krzysiek R; Galanaud P; Levy Y; Emilie D
    Blood; 2001 Sep; 98(6):1678-86. PubMed ID: 11535497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2.
    Zeng Y; Jiang J; Huebener N; Wenkel J; Gaedicke G; Xiang R; Lode HN
    Cancer Lett; 2005 Oct; 228(1-2):187-93. PubMed ID: 15953676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemokines and immunomodulation: applications for HIV infections].
    Théodorou I; Combadière C; Faure S; Debré P
    J Soc Biol; 2002; 196(1):7-11. PubMed ID: 12134637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DC-SIGNR polymorphisms and its association with HIV-1 infection].
    Wang H; Wang C; Feng T; Zhou H; Li L; Wang F; Zhao G; Zhu T; Zhou B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):542-5. PubMed ID: 18841568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine: moving from chemotaxis to neuroprotection.
    Ré DB; Przedborski S
    Nat Neurosci; 2006 Jul; 9(7):859-61. PubMed ID: 16801915
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
    Zhang X; Wei H; Chen Q; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of fractalkine by endothelial cells under shear stress.
    Moatti D; Vele O; Nemerson Y
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):197. PubMed ID: 15091008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Host genetic polymorphisms in the pathogenesis of HIV-1 infection].
    Shioda T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):89-93. PubMed ID: 11963186
    [No Abstract]   [Full Text] [Related]  

  • 14. Global human genetics of HIV-1 infection and China.
    Zhu TF; Feng TJ; Xiao X; Wang H; Zhou BP
    Cell Res; 2005; 15(11-12):833-42. PubMed ID: 16354556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of breviscapine on fractalkine expression in chronic hypoxic rats.
    Chen XJ; Cheng DY; Yang L; Xia XQ; Guan J
    Chin Med J (Engl); 2006 Sep; 119(17):1465-8. PubMed ID: 16989748
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.
    Brueckmann M; Borggrefe M
    Gut; 2007 Mar; 56(3):314-6. PubMed ID: 17339240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
    Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.
    Oh DY; Baumann K; Hamouda O; Eckert JK; Neumann K; Kücherer C; Bartmeyer B; Poggensee G; Oh N; Pruss A; Jessen H; Schumann RR
    AIDS; 2009 Jan; 23(3):297-307. PubMed ID: 19114863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.
    Sato E; Iikuni N; Yoshio T; Minota S; Kamatani N; Okamoto H
    Ann Rheum Dis; 2006 Sep; 65(9):1257-9. PubMed ID: 16905589
    [No Abstract]   [Full Text] [Related]  

  • 20. The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvement.
    Morabito F; Merendino RA; Penna G; Cuzzola M; Stelitano C; Callea V; Di Pasquale G; Minciullo PL; Gangemi S
    Acta Haematol; 2005; 113(2):152-4. PubMed ID: 15802897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.